Manchester Capital Management’s Evolent Health EVH Stock Holding History

Manchester Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-112	Closed	-$3.63K	–	1010
2023 Q1	$3.63K	Hold	112	–	–	﹤0.01%	673
2022 Q4	$3.15K	Sell	112 -15	-12%	-$430	﹤0.01%	606
2022 Q3	$5K	Sell	127 -492	-79%	-$17.3K	﹤0.01%	511
2022 Q2	$19K	Buy	619 +107	+21%	+$3.12K	﹤0.01%	420
2022 Q1	$17K	Sell	512 -508	-50%	-$13.3K	﹤0.01%	483
2021 Q4	$28K	Hold	1,020	–	–	﹤0.01%	447
2021 Q3	$32K	Buy	+1,020	New	+$24.5K	﹤0.01%	465
2019 Q2	–	Sell	-909	Closed	-$11K	–	582
2019 Q1	$11K	Buy	+909	New	+$14.4K	﹤0.01%	558

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Manchester Capital Management's EVH Position: Q2 2023 in Review

Manchester Capital Management sold out of Evolent Health (EVH) in Q2 2023, closing a stake of 112 shares — an estimated $3.63K sold.

Manchester Capital Management first reported a position in EVH in Q1 2019 and held it in 8 quarters. The position peaked at $32K in Q3 2021. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

Manchester Capital Management reported no remaining Evolent Health position as of Q2 2023 after selling out during the quarter.
Manchester Capital Management sold 112 Evolent Health shares in Q2 2023, an estimated $3.63K.
Manchester Capital Management first reported a position in Evolent Health in Q1 2019 and held it in 8 quarters.
Manchester Capital Management's Evolent Health position peaked at $32K in Q3 2021.
217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on Manchester Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.